Acadia Healthcare Company, Inc. - Common Stock, par value $0.01 per share (ACHC)

Historical Holders from Q1 2014 to Q3 2025

Symbol
ACHC on Nasdaq
CUSIP
00404A109
Type / Class
Equity / Common Stock, par value $0.01 per share
Shares outstanding
92.3M
All holders as of September 30, 2025
Q3 2025
Total 13F shares, excl. options
114M
Holdings value
$2.81B
% of all portfolios
0.009%
Grand Portfolio weight change
+0%
Number of holders
261
Number of buys
139
Number of sells
-154
Average Value change %
+0%
Average buys %
+0.003%
Average sells %
-0.002%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of Acadia Healthcare Company, Inc. - Common Stock, par value $0.01 per share (ACHC)

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
BlackRock, Inc. 11.2% $218M 10.3M BlackRock, Inc. Sep 30, 2025
WELLINGTON MANAGEMENT GROUP LLP 10.2% +11.1% $233M $24.6M 9.42M +11.8% Wellington Management Group LLP Sep 30, 2025
VANGUARD GROUP INC 10.19% $233M 9.42M The Vanguard Group Sep 30, 2025
Khrom Investments Fund, LP 7.74% +44.8% $164M $48.3M 7.15M +41.6% Eric Khrom Nov 20, 2025
FMR LLC 6.7% $138M 6.23M FMR LLC Dec 31, 2024
T. Rowe Price Investment Management, Inc. 1% $21M 950K T. Rowe Price Investment Management, Inc. Mar 31, 2025

Institutional Holders of Acadia Healthcare Company, Inc. - Common Stock, par value $0.01 per share (ACHC)

Period Reported Shares, Excl. Options Value, Excl. Options Change Price Investors
2025 Q3 114M $2.81B +$196M $24.76 261
2025 Q2 106M $2.41B +$104M $22.69 292
2025 Q1 100M $3.04B -$83.2M $30.32 290
2024 Q4 100M $3.98B -$244M $39.65 300
2024 Q3 98.3M $6.23B +$94.5M $63.41 309
2024 Q2 96.7M $6.53B +$228M $67.54 303
2024 Q1 93.2M $7.38B +$49.4M $79.22 313
2023 Q4 92.5M $7.19B +$61.8M $77.76 304
2023 Q3 91.5M $6.43B -$110M $70.31 287
2023 Q2 93.1M $7.41B +$21.9M $79.64 275
2023 Q1 92.8M $6.71B +$108M $72.25 302
2022 Q4 91.4M $7.52B -$147M $82.32 339
2022 Q3 93.2M $7.29B -$737M $78.18 308
2022 Q2 93.1M $6.29B +$219M $67.63 276
2022 Q1 90.4M $5.92B +$5.68M $65.53 281
2021 Q4 90.3M $5.48B -$5.66M $60.70 269
2021 Q3 90.2M $5.75B +$14.6M $63.78 286
2021 Q2 90M $5.65B -$40.8M $62.75 283
2021 Q1 90.7M $5.18B +$27.6M $57.14 267
2020 Q4 90.6M $4.55B -$106M $50.26 258
2020 Q3 92.9M $2.74B -$55.1M $29.48 218
2020 Q2 94.9M $2.38B -$51.5M $25.12 206
2020 Q1 97.7M $1.79B -$214M $18.35 202
2019 Q4 103M $3.41B -$50.2M $33.22 233
2019 Q3 104M $3.23B -$110M $31.08 215
2019 Q2 107M $3.75B +$13.7M $34.95 231
2019 Q1 108M $3.16B +$165M $29.31 244
2018 Q4 103M $2.66B -$98.3M $25.71 243
2018 Q3 106M $3.74B +$77.5M $35.20 247
2018 Q2 104M $4.25B -$240M $40.91 248
2018 Q1 110M $4.29B +$123M $39.18 235
2017 Q4 107M $3.5B -$267M $32.63 259
2017 Q3 112M $5.34B -$71.6M $47.76 266
2017 Q2 114M $5.61B +$366M $49.38 254
2017 Q1 111M $4.84B +$734M $43.60 231
2016 Q4 99M $3.28B +$103M $33.10 230
2016 Q3 92.8M $4.6B +$272M $49.55 250
2016 Q2 88M $4.87B +$188M $55.40 248
2016 Q1 84.5M $4.66B +$1.04B $55.11 236
2015 Q4 65.4M $4.08B +$114M $62.46 231
2015 Q3 63.5M $4.21B +$164M $66.27 248
2015 Q2 57.3M $4.49B +$168M $78.33 237
2015 Q1 58.7M $4.2B +$521M $71.60 203
2014 Q4 51.3M $3.14B -$21.4M $61.21 193
2014 Q3 51.7M $2.5B +$72.5M $48.50 173
2014 Q2 50.3M $2.29B +$423M $45.50 181
2014 Q1 40.7M $1.83B +$47.9M $45.12 160